Management by Primary Care Clinicians of Patients Suspected of Having Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infections Final Contract Report Results (continued) Univariate Analysis of SSTIsThe univariate findings for procedures and cultures were performed only on 680.x ICD-9 codes, because the majority of 681.x-682.x codes are cellulitis, for which procedures and cultures cannot be done. There was a significant decrease in the procedure rate in WHA and combined systems, but not in MCNT (Table 4). However, overall, the procedure rate was unexpectedly low, as was the culture rate. The culture rate was higher than the procedure rate, which suggests that in some cases cultures were obtained even though there was no procedure performed or the procedure was not detected in the electronic billing data. Table 4. Pre-intervention and intervention rates for procedures and cultures of purulent SSTIs (680.x) MCNTWHACombined PreInterventionp ValuePreInterventionp ValuePreInterventionp ValueTotal cases (n)11846 175102 293148 Procedures (n)22 285 307 Procedures (%)1.694.350.322516.094.90.0060 10.274.730.0488 Culture (n)213 2918 5021 Culture (%)17.86.520.066516.6717.650.818117.1214.190.4378Key: MCNT = Medical Clinic of North Texas, WHA = Wilmington Health Associates.In total, there were 316 cultures that were positive for S. aureus in the two systems; of these, 208 (65.8 percent) were MRSA. MRSA was highly prevalent in both systems prior to the intervention, and this did not substantially change during the intervention period. Table 5 shows the breakdown by time period and system. Table 5. Proportion of S. aureus cultures that were MRSA MCNTWHACombinedPre-intervention91/139 (65.5%)69/106 (65.1%)160/245 (65.3%)Intervention12/21 (57.1%)36/50 (72.0%)48/71 (67.6%)All time periods103/161(64.0%)105/156 (67.3%)208/316 (65.8%)Key: MCNT = Medical Clinic of North Texas, WHA = Wilmington Health Associates.For antibiotic usage and antibiotic choice (whether MRSA was covered when antibiotics were prescribed), the univariate analysis was performed separately on 680.x infections (Table 6 and Figure 1) and 681.x-682.x infections (Table 7 and Figure 2). This was because the antibiotics may be less indicated in general for a purulent infection that is fully drained (which may include most of 680.x cases) but, when used, should cover MRSA. For 681.x-682.x cases, of which the majority may be cellulitis infections that are not purulent, antibiotics are clearly indicated and coverage of MRSA is less imperative, according to the CDC guidelines. The combined 680.x-682.x is also presented below (Table 8). Compared to the pre-intervention period, antibiotic use increased in both systems for all ICD-9 groupings during the intervention period. The proportion of antibiotics that covered MRSA increased significantly in WHA and the two systems combined in the 681.x-682.x and all ICD-9 codes combined, whereas there was a trend for an increase in MRSA antibiotic use in MCNT within the 681.x-682.x and all ICD-9 codes combined. In the 680.x cases, there was a trend for increased MRSA antibiotic usage in WHA. Clinicians in MCNT used antibiotics more often than in WHA. Table 6. Antibiotic usage for purulent cases (680.x) and if MRSA-covering antibiotic MCNTWHACombined Pre-IntervensionInterventionp ValuePre-InterventionInterventionp ValuePre-InterventionInterventionp ValueTotal number of 680.x cases (n)11846 175102 293148 Antibiotics prescribed (n)6332 4437 10769 Antibiotics prescribed (%)53.3969.570.059425.1436.270.049536.5246.62<.0001MRSA-covering antibiotics (n)3418 914 4332 MRSA-covering antibiotics (%)53.9756.250.832820.4537.840.083940.1946.380.4175Key: MCNT = Medical Clinic of North Texas, WHA = Wilmington Health Associates. Figure 1. 680.x Skin infections and antibiotic prescribing rates in WHA, MCNT, and combinedKey: MCNT = Medical Clinic of North Texas, WHA = Wilmington Health Associates.[D] Select for Text Description. Table 7. Antibiotic usage for 681.x-682.x cases and if MRSA-covering antibiotic MCNTWHACombined Pre-0 InterventionInterventionp ValuePre-InterventionInterventionp ValuePre-InterventionInterventionp ValueTotal number of 681.x-682.x cases1752597 1067661 28191258 Antibiotics prescribed (n)738368 265202 1003570 Antibiotics prescribed (%)42.1261.64<.000124.8430.560.009235.5845.31<.0001MRSA-covering antibiotics (n)289166 4956 338222 MRSA-covering antibiotics (%)39.1645.11.058218.4927.720.017933.738.950.0366 Figure 2. 681.x�682.x Skin infections and antibiotic prescribing rates in WHA, MCNT, and combinedKey: MCNT = Medical Clinic of North Texas, WHA = Wilmington Health Associates.[D] Select for Text Description. Table 8. Antibiotic usage for all SSTI (680.x-682.x) cases and if MRSA-covering antibiotic MCNTWHACombined Pre-InterventionInterventionp ValuePre-InterventionInterventionp ValuePre-InterventionInterventionp ValueTotal number of cases1870643 1240802 31101447 Antibiotics prescribed (n)801400 309239 1110639 Antibiotics prescribed (%)42.8362.21<.000124.8831.32<.001735.6745.45<.0001MRSA-covering antibiotics (n)323184 5870 381254 MRSA-covering antibiotics (%)40.3246.060518.7729.290.003934.3239.750.0231Key: MCNT = Medical Clinic of North Texas, WHA = Wilmington Health Associates.Return to Contents Multivariate AnalysesThe multivariate analyses adjusted for patient demographic and clinical characteristics and the findings are presented in the tables below (Tables 9-16). The intervention was associated with a trend toward a decreased likelihood of performing a drainage procedure but no significant effect on obtaining cultures (680.x cases only). The intervention increased the likelihood of prescribing antibiotics and that the antibiotics prescribed would cover MRSA.Procedures Table 9. Odds ratio estimates for procedures performed on purulent SSTIs (680.x) n=436 total cases in this regressionEffectOdds Ratio95% Confidence Limitsp ValueIntervention period n=148 cases that were in intervention period0.36420.11241.17960.0921Child or adolescent n=144 children/adolescents3.17411.007110.00350.0486Male n=191 males2.23391.28973.86920.0041Previous case of MRSA n=86 with a previous case0.72310.34651.5090.3877MCNT patient n=164 from MCNT0.38780.0951.58360.187Diabetes n=60 with diabetes2.38390.77377.34550.1303Specialty. IM vs. FM: n=82 patients of FM n=139 patients of IM0.71220.17032.97850.642Specialty: PA/NP vs. FM n=84 patients of PA/NP0.23230.04511.19570.0808Specialty: Peds vs. FM n=131 patients of Peds0.6150.15312.47020.4932Key: MCNT = Medical Clinic of North Texas, IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics.Cultures Table 10. Odds ratios for cultures obtained on purulent SSTIs (680.x) n=436 total cases in this regressionEffectOdds Ratio95% Confidence Limitsp ValueIntervention period n=148 cases that were in intervention period0.93540.52551.6650.8204Child or adolescent n=144 children/adolescents1.94680.71965.26720.1896Male n=191 males1.84851.10973.07930.0183Previous case of MRSA n=86 with a previous case0.56920.32351.00150.0506MCNT patient n=164 from MCNT0.55630.23731.3040.1772Diabetes n=60 with diabetes1.24380.57562.6880.5789Specialty. IM vs. FM: n=82 patients of FM n=139 patients of IM2.2060.55358.79180.2621Specialty: PA/NP vs. FM n=84 patients of PA/NP8.98552.163237.32450.0025Specialty: Peds vs. FM n=131 patients of Peds2.42390.57510.21870.2278Antibiotics Table 11. Among 680.x cases, odds ratios for receiving antibiotics n=436 total cases in this regressionEffectOdds Ratio95% Confidence Limitsp ValueIntervention period n=148 cases that were in intervention period2.1831.44293.30260.0002Child or adolescent n=144 children/adolescents0.36280.14880.88460.0258Male n=191 males1.03330.68211.56510.8773Previous case of MRSA n=86 with a previous case0.80140.43271.4840.4812MCNT patient n=164 from MCNT2.73451.56674.77260.0004Diabetes n=60 with diabetes0.55320.3230.94770.0311Specialty. IM vs. FM: n=82 patients of FM n=139 patients of IM0.65850.37861.14510.1389Specialty: PA/NP vs. FM n=84 patients of PA/NP1.60380.6963.69570.2674Specialty: Peds vs. FM n=131 patients of Peds2.5971.0286.5590.0436Key: MCNT = Medical Clinic of North Texas, IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics. Table 12. Among all cases (680-2.x), odds ratios for receiving antibiotics n = 4,457 total cases in this regressionEffectOdds Ratio95% Confidence Limitsp ValueIntervention n=1,406 cases that were in intervention period1.78061.49212.1248<.0001Child or adolescent (age<18) n=1,105 children/adolescents1.05570.85391.30510.6168Male n=815 males1.10090.98511.23020.0899Previous case of MRSA n=708 with a previous case0.92870.76091.13360.4672MCNT patient n=2,513 patients from MCNT3.08092.40683.9438<.0001Diabetes n=767 patients with diabetes0.85950.71451.03390.1083Specialty. IM vs. FM n=1,483 patients of IM n=1,637 patients of FM0.85860.61091.20670.3801Specialty: PA/NP vs. FM n=522 patients of PA/NP1.08490.66061.78180.7474Specialty: Peds vs. FM n=815 patients of Peds1.26640.92081.74160.1464ICD-9 of 680.x vs. 681.x-682.x n=441 patients with a 680.x diagnosis1.02790.80411.31400.8260Key: MCNT = Medical Clinic of North Texas, IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics, ICD-9 = International Classification of Diseases-9.MRSA-covering antibiotics Table 13. 680.x cases only, odds ratios for receiving a MRSA-covering antibiotic n=436 total cases in this regressionEffectOdds Ratio95% Confidence Limitsp ValueIntervention period n=148 cases that were in intervention period2.62411.49554.60440.0008Child or adolescent n=144 children/adolescents1.14170.58032.24620.701Male n=191 males1.27340.72522.2360.4002Previous case of MRSA n=86 with a previous case1.1650.46932.89210.742MCNT patient n=164 from MCNT4.29182.28368.0662<.0001Diabetes n=60 with diabetes0.92620.44551.92550.8373Specialty. IM vs. FM: n=82 patients of FM n=139 patients of IM2.7620.98847.71780.0527Specialty: PA/NP vs. FM n=84 patients of PA/NP6.5092.41617.540.0002Specialty: Peds vs. FM n=131 patients of Peds2.4590.7338.2450.1449Key: MCNT = Medical Clinic of North Texas, IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics. Table 14. Among all cases 680.x-682.x, odds ratios for receiving a MRSA-covering antibiotic n=4,457 total cases for this regressionEffectOdds Ratio95% Confidence LimitspValueIntervention n=1,406 cases that were in intervention period1.93521.53212.4444<.0001Child or adolescent(age<18) n=1,105 children/adolescents0.82700.59861.14260.2495Male n=815 males1.16150.99601.35450.0563Previous case of MRSA n=708 with a previous case0.92180.69811.21700.5656MCNT patient n=2,513 patients from MCNT4.40093.07936.2899<.0001Diabetes n=767 patients with diabetes0.88470.69611.12430.3164Specialty. IM vs. FM n=1,483 patients of IM n=1,637 patients of FM0.76040.49391.17080.2136Specialty: PA/NP vs. FM n=522 patients of PA/NP1.21270.77511.89740.3984Specialty: Peds vs. FM n=815 patients of Peds1.79641.15682.78960.0091ICD-9 of 680.x vs. 681.x-682.x n=441 patients with a 680.x diagnosis1.59350.98372.58110.0583Key: MCNT = Medical Clinic of North Texas, IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics, ICD-9 = International Classification of Diseases-9 Table 15. If an antibiotic was prescribed (680.x-682.x cases), odds ratios for receiving a MRSA-covering antibiotic (model excludes cases in which no antibiotic was prescribed) n=1,717 total cases in this regressionEffectOdds Ratio95% Confidence Limitsp ValueIntervention n=626 cases that were in intervention period1.41081.08031.84250.0115Child or adolescent (age<18) n=452 children/adolescents0.71690.49111.04660.0847Male n=815 males1.12530.91441.38470.2649Previous case of MRSA n=271 with a previous case1.01320.74441.37900.9336MCNT patient n=1,173 patients from MCNT2.30041.60743.2920<.0001Diabetes n=239 patients with diabetes1.04540.80251.36170.7421Specialty. IM vs. FM n=478 patients of IM n=656 patients of FM0.85380.57201.27450.4394Specialty: PA/NP vs. FM n=240 patients of PA/NP1.14380.75591.73060.5249Specialty: Peds vs. FM n=343 patients of Peds1.52830.91982.53950.1016ICD-9 of 680.x vs. 681.x-682.x n=173 patients with a 680.x diagnosis1.71280.96983.02500.0637Key: MCNT = Medical Clinic of North Texas, IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics, ICD-9 = International Classification of Diseases-9. Table 16. Among 681.x-682.x cases, odds ratios for prescribed antibiotics and prescribed MRSA-covering antibiotics AntibioticsMRSA-Covering AntibioticsEffectOdds Ratio95% Wald Confidence Limitsp ValueOdds Ratio95% Wald Confidence Limitsp ValueIntervention period Monthly change1.1221.0711.175<.00011.1261.0561.201<0.001Historical period Monthly change1.0501.0241.0760.00011.04381.0081.0790.014Child or adolescent (age<18)1.1330.9041.4210.2750.7840.5511.1160.178Male1.0990.9761.2370.1161.1430.9731.3420.102Previous case of MRSA0.8760.6981.0990.2530.8350.6141.1350.251Texas clinics patient2.9722.2743.884<.00014.0342.7355.950<.0001Diabetes0.8950.7361.0890.27040.8860.6911.1360.343Specialty. IM vs FM0.8660.6101.2300.4220.6930.4421.0880.111Specialty: PA/NP vs FM1.0600.6321.7750.8260.9360.5461.6040.810Specialty: Peds vs FM1.1710.8281.6560.3711.7701.0962.8590.020Key: IM = internal medicine, FM = family medicine, PA = physician assistant, NP = nurse practitioner, Peds = pediatrics.Some other associations regarding clinicians include that pediatricians were more likely to cover MRSA, midlevels were more likely to obtain a culture, and providers at MCNT were more likely to prescribe antibiotics and more likely to cover MRSA when antibiotics were prescribed. Male patients were twice as likely to have drainage procedures done and were also twice as likely to get cultures done. Patients with diabetes were less likely to have antibiotics prescribed (680.x, cases only).Return to Contents Proceed to Next Section Current as of March 2011 Internet Citation: Management by Primary Care Clinicians of Patients Suspected of Having Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infections: Final Contract Report. March 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/mrsa/colorado_mrsa2.html